Abstract Details

Title Phase I Clinical Trial Demonstrates Safety and Efficacy of Intrathecal Autologous Mesenchymal Stem Cell-Derived Neural Progenitors (MSC-NPs) for the Treatment of Progressive Multiple Sclerosis

Topic Multiple Sclerosis

Presentation(s) P5 - (-)

Poster/Presentation
Number 378

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Violaine K. Harris, PhD (Tisch Multiple Sclerosis Research Center of NY) PRESENTER	No disclosure on file
James Stark, MD, FAAN (IMSMP)	Dr. Stark has nothing to disclose.
Gloria J. Joo (Tisch MS Research Center of NY)	No disclosure on file
Tamara Vyshkina, PhD (Tisch Multiple Sclerosis Research Ctr of NY)	No disclosure on file
Saud A. Sadiq, MD, MB, FAAN (Tisch Multiple Sclerosis Research Center of New York)	Dr. Sadiq has nothing to disclose.